Bicanalicular intubation is effective and atraumatic

Article

Modified bicanalicular intubation is effective and atraumatic for the management of canalicular lacerations in adults.

Modified bicanalicular intubation is effective and atraumatic for the management of canalicular lacerations in adults, claims a study in the journal Eye.

Dr X. Liang et al., State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Centre, China, performed surgical procedures on 35 eyes in 35 adult patients from October 2007 to September 2009. The silicone tubes were inserted through the lacrimal punctum using a modified soft probe. The tubes were left in the bicanaliculi for 3-10 months.

The procedure was successfully performed in all eyes. After 3-10 months the tubes were removed and the mean follow-up time after the removal was 13.8 months.

Only one eye experienced splitting in the lower punctum after surgery. There were no other complications recorded that were linked to the silicone tubes and all tubes were successfully removed.

The modified bicanalicular intubation procedure is associated with fewer complications than traditional sutures for canalicular lacerations in adults.

To read the abstract please click here.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.